Kristyn Rene Aalto
Chief Executive Officer at Orlance, Inc.
Kristyn Rene Aalto active positions
Companies | Position | Start | End |
---|---|---|---|
Bard Access Systems, Inc.
Bard Access Systems, Inc. Medical SpecialtiesHealth Technology Bard Access Systems, Inc. develops, manufactures and distributes medical devices. It makes vascular access products as dialysis & pheresis catheters, implanted ports, ultrasound systems and surgical accessories. The company was founded in 1947 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 2009-10-26 | - |
Leibinger LP | Corporate Officer/Principal | 2009-10-26 | - |
University of Michigan | Corporate Officer/Principal | 2009-10-26 | - |
Orlance, Inc. | Chief Executive Officer | - | - |
Career history of Kristyn Rene Aalto
Former positions of Kristyn Rene Aalto
Companies | Position | Start | End |
---|---|---|---|
Arboretum Ventures LLC
Arboretum Ventures LLC Investment ManagersFinance Arboretum Ventures LLC (Arboretum Ventures) is a venture capital firm founded in 2002 by Jan L. Garfinkle and Tim B. Petersen. The firm is headquartered in Ann Arbor, Michigan. | Corporate Officer/Principal | 2007-09-30 | 2008-09-29 |
Aursos, Inc.
Aursos, Inc. Pharmaceuticals: MajorHealth Technology Aursos, Inc. develops and markets biopharmaceutical products. The company was founded by Seth Donahue and Ronald J. Shebuski Sr. in March 2007 and is headquartered in Kalamazoo, MI. | Director/Board Member | - | - |
Chief Executive Officer | - | - | |
President | - | - | |
Accord Biosciences, Inc.
Accord Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Accord Biomaterials, Inc., based in Ann Arbor, MI, focuses upon the development of Nogen nitric oxide materials for use in biomarker assays, diagnostic tools and blood-contacting medical devices. Nogen materials liberate nitric oxide from carrier molecules within blood known as nitrosothiols ('RSNOs'), enabling the development of tools that precisely quantitative RSNO levels in blood and vascular device coatings that resist clotting and infection due to nitric oxide's inherent antiplatelet and antimicrobial effects. Accord collaborates with incubator MC3 Corporation, the Cleveland Clinic and best-in-class development partners and holds an exclusive license to Nogen technology from the University of Michigan. Privately-held and venture-backed, Accord is committed to accelerating clinical validation and utility of this technology. | Corporate Officer/Principal | - | 2010-07-20 |
President | 2010-07-20 | - |
Training of Kristyn Rene Aalto
Marquette University | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
Corporate Officer/Principal | 5 |
President | 2 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Electronic Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Aursos, Inc.
Aursos, Inc. Pharmaceuticals: MajorHealth Technology Aursos, Inc. develops and markets biopharmaceutical products. The company was founded by Seth Donahue and Ronald J. Shebuski Sr. in March 2007 and is headquartered in Kalamazoo, MI. | Health Technology |
Bard Access Systems, Inc.
Bard Access Systems, Inc. Medical SpecialtiesHealth Technology Bard Access Systems, Inc. develops, manufactures and distributes medical devices. It makes vascular access products as dialysis & pheresis catheters, implanted ports, ultrasound systems and surgical accessories. The company was founded in 1947 and is headquartered in Salt Lake City, UT. | Health Technology |
Accord Biosciences, Inc.
Accord Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Accord Biomaterials, Inc., based in Ann Arbor, MI, focuses upon the development of Nogen nitric oxide materials for use in biomarker assays, diagnostic tools and blood-contacting medical devices. Nogen materials liberate nitric oxide from carrier molecules within blood known as nitrosothiols ('RSNOs'), enabling the development of tools that precisely quantitative RSNO levels in blood and vascular device coatings that resist clotting and infection due to nitric oxide's inherent antiplatelet and antimicrobial effects. Accord collaborates with incubator MC3 Corporation, the Cleveland Clinic and best-in-class development partners and holds an exclusive license to Nogen technology from the University of Michigan. Privately-held and venture-backed, Accord is committed to accelerating clinical validation and utility of this technology. | Electronic Technology |
Leibinger LP | |
Orlance, Inc. | |
Arboretum Ventures LLC
Arboretum Ventures LLC Investment ManagersFinance Arboretum Ventures LLC (Arboretum Ventures) is a venture capital firm founded in 2002 by Jan L. Garfinkle and Tim B. Petersen. The firm is headquartered in Ann Arbor, Michigan. | Finance |
- Stock Market
- Insiders
- Kristyn Rene Aalto
- Experience